Allinaire Therapeutics Launches to Combat Pulmonary Diseases

CLEVELAND, OH – May 2, 2016
BioMotiv and Indiana University Research and Technology Corporation announce the formation of Allinaire Therapeutics, a biotechnology start-up company that aims to develop novel therapeutics for pulmonary diseases.

Allinaire Therapeutics is based on intellectual property from the Indiana University School of Medicine, developed by scientific founders, Irina Petrache, MD, a Harrington Scholar-Innovator, and Matthias Clauss, PhD.